FDA recall D-0150-2018

Pfizer Inc. · Class I · drug

Product

diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1), b) 1000-count bottle (NDC 59762-1061-2), Rx Only, Distributed by: Greenstone LLC. Peapack, NJ 07977

Reason for recall

SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent

Distribution

Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2017-10-20
Report date
2018-01-10
Termination date
2020-06-02
Voluntary/Mandated
Voluntary: Firm initiated
Location
New York, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0150-2018